In This Section

Newsroom

July 27, 2020
$7.2M Grant From National Institute on Drug Abuse Allows Temple Scientists to Continue Critical Research on Drugs of Abuse

For the last two decades, scientists at Temple's Center for Substance Abuse Research (CSAR) have been working to advance the understanding of the biological basis of drug addiction and actions of drugs of abuse. Now, thanks to a $7.2M grant from the National Institute on Drug Abuse (NIDA), that work is funded for another five years. This is the fourth 5-year renewal of the NIDA P30 Core Center of Excellence grant awarded to CSAR.
- VIEW STORY
July 22, 2020
Temple Receives $5 Million Gift from Dr. Gerald M. Lemole and Emily Jane Lemole to Establish The Lemole Center for Integrated Lymphatics Research

Gerald M. Lemole, MD, a 1962 graduate of the Lewis Katz School of Medicine at Temple University (LKSOM), and Emily Jane Lemole have committed a gift of $5 million to LKSOM to establish The Lemole Center for Integrated Lymphatics Research. Guided by a strong establishing vision, this groundbreaking new center will integrate basic science research and clinical research to establish a high-performing interdisciplinary hub for lymphatics research to target the lymphatic system in understanding, treating and curing human disease.
- VIEW STORY
July 09, 2020
Temple Scientists Identify Key Factor Regulating Abnormal Heart Growth

In a paper published online in the journal Circulation, Temple scientists are the first to show that molecular regulator FoxO1 attaches to and activates a wide array of genes in heart cells.
- VIEW STORY
July 09, 2020
Reactive Arthritis is Fueled by Amyloid Protein During Salmonella Infection, Temple Scientists Report

In new work, Temple researchers show that in mice infected with Salmonella enterica Typhimurium – a common cause of food-borne diarrheal illness – curli provokes the generation of autoantibodies and joint inflammation. The most damaging of these effects were linked to systemic exposure to curli, revealing a hidden harm inflicted by bacterial components that escape the intestinal tract.
- VIEW STORY
July 07, 2020
Temple Treats First Patients in the U.S. in Clinical Trial of Novel Immunotherapy for Patients with COVID-19

Temple has treated the first five patients in the United States as part of a Phase 1 clinical trial investigating a novel immunotherapy approach for patients with COVID-19. CPI-006, developed by Corvus Pharmaceuticals, Inc., has demonstrated a potential new approach to immunotherapy of infectious diseases and cancer.
- VIEW STORY
June 17, 2020
Temple’s Dr. Walter J. Koch to Receive the International Society for Heart Research 2020 Research Achievement Award

Temple's Walter J. Koch, PhD has been selected as the recipient of the 2020 Research Achievement Award (RAA) – the most prestigious honor given to a senior researcher by the International Society for Heart Research (ISHR).
- VIEW STORY
June 16, 2020
$1.77M Award from National Institute on Drug Abuse Gives Temple Researchers Chance To Investigate Novel Therapy for Cocaine Addiction

Thanks to a new $1.77M grant from the National Institute on Drug Abuse (NIDA), Temple researchers are able to explore whether a drug called clavulanic acid can help patients recover from cocaine use disorder.
- VIEW STORY
June 02, 2020
#FitForTheFrontLine Challenge Unites Temple Health, Other Top Medical Centers in Support of Front-Line Health Care Workers

Medical centers across the United States, including Temple Health, are joining forces to start a country-wide movement of physical activity to honor and support front-line health care workers who have worked tirelessly to save lives. #FitForTheFrontLine is a national fitness challenge beginning Tuesday, May 26, and culminating on Sunday, June 14 (Flag Day). The event encourages Americans young and old to move, exercise, and get fit to increase awareness and raise funds to support our nation’s health care heroes.
- VIEW STORY

Newsroom

Pages